Clover Health Investments (CLOV) Net Income towards Common Stockholders (2020 - 2024)
Historic Net Income towards Common Stockholders for Clover Health Investments (CLOV) over the last 5 years, with Q4 2024 value amounting to -$643000.0.
- Clover Health Investments' Net Income towards Common Stockholders rose 7455.48% to -$643000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was -$643000.0, marking a year-over-year decrease of 14904.65%. This contributed to the annual value of $3.3 million for FY2024, which is 20136.94% up from last year.
- Latest data reveals that Clover Health Investments reported Net Income towards Common Stockholders of -$643000.0 as of Q4 2024, which was up 7455.48% from -$400000.0 recorded in Q3 2024.
- In the past 5 years, Clover Health Investments' Net Income towards Common Stockholders registered a high of $14.7 million during Q2 2020, and its lowest value of -$187.2 million during Q4 2021.
- In the last 5 years, Clover Health Investments' Net Income towards Common Stockholders had a median value of -$25.3 million in 2020 and averaged -$48.9 million.
- As far as peak fluctuations go, Clover Health Investments' Net Income towards Common Stockholders plummeted by 134598.79% in 2021, and later soared by 21733.33% in 2024.
- Quarter analysis of 5 years shows Clover Health Investments' Net Income towards Common Stockholders stood at -$78.1 million in 2020, then plummeted by 139.81% to -$187.2 million in 2021, then skyrocketed by 87.98% to -$22.5 million in 2022, then soared by 88.77% to -$2.5 million in 2023, then surged by 74.55% to -$643000.0 in 2024.
- Its Net Income towards Common Stockholders stands at -$643000.0 for Q4 2024, versus -$400000.0 for Q3 2024 and $238000.0 for Q2 2024.